Abstract
Cardiac ischemia/reperfusion injury is associated with the formation and action of lipid mediators derived from polyunsaturated fatty acids. Among them, linoleic acid (LA) is metabolized to epoxyoctadecanoic acids (EpOMEs) by cytochrome P450 (CYP) epoxygenases and further to dihydroxyoctadecanoic acids (DiHOMEs) by soluble epoxide hydrolase (sEH). We hypothesized that EpOMEs and/or DiHOMEs may affect cardiac post-ischemic recovery and addressed this question using isolated murine hearts in a Langendorff system. Hearts from C57Bl6 mice were exposed to 12,13-EpOME, 12,13-DiHOME, or vehicle (phosphate buffered sodium; PBS). Effects on basal cardiac function and functional recovery during reperfusion following 20 min of ischemia were investigated. Electrocardiogram (ECG), left ventricular (LV) pressure and coronary flow (CF) were continuously measured. Ischemia reperfusion experiments were repeated after administration of the sEH-inhibitor 12-(3-adamantan-1-yl-ureido)dodecanoic acid (AUDA). At a concentration of 100 nM, both EpOME and DiHOME decreased post-ischemic functional recovery in murine hearts. There was no effect on basal cardiac parameters. The detrimental effects seen with EpOME, but not DiHOME, were averted by sEH inhibition (AUDA). Our results indicate that LA-derived mediators EpOME/DiHOME may play an important role in cardiac ischemic events. Inhibition of sEH could provide a novel treatment option to prevent detrimental DiHOME effects in acute cardiac ischemia.
Similar content being viewed by others
Abbreviations
- AUDA:
-
12-(3-Adamantan-1-yl-ureido)dodecanoic acid
- CF:
-
Coronary flow
- CYP:
-
Cytochrome P450
- DiHOME:
-
Dihydroxyoctadecanoic acid
- EET:
-
Epoxyeicosatrienoic acid
- EpOME:
-
Epoxyoctadecanoic acid
- HR:
-
Heart rate
- LA:
-
Linoleic acid
- LV:
-
Left ventricle
- LVdia:
-
Left ventricular diastolic pressure
- LVDP:
-
Left ventricular developed pressure
- PBS:
-
Phosphate-buffered sodium
- sEH:
-
Soluble epoxide hydrolase
References
Pagidipati, N. J., & Gaziano, T. A. (2013). Estimating deaths from cardiovascular disease: a review of global methodologies of mortality measurement. Circulation, 127, 749–756.
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., … Turner, M. B. (2015). Heart disease and stroke statistics–2015 update: a report from the American Heart Association. Circulation, 131, e29–e322.
Cleland, J. G., Torabi, A., & Khan, N. K. (2005). Epidemiology and management of heart failure and left ventricular systolic dysfunction in the aftermath of a myocardial infarction. Heart, 91(Suppl 2), ii7–ii13; discussion ii31, ii43-18.
Frangogiannis, N. G., Smith, C. W., & Entman, M. L. (2002). The inflammatory response in myocardial infarction. Cardiovascular Research, 53, 31–47.
Eliasz, A. W., Chapman, D., & Ewing, D. F. (1976). Phospholipid phase transitions. Effects of n-alcohols, n-monocarboxylic acids, phenylalkyl alcohols and quaternary ammonium compounds. Biochimica et Biophysica Acta, 448, 220–230.
Schuchardt, J. P., Schmidt, S., Kressel, G., Dong, H., Willenberg, I., Hammock, B. D., Hahn, A., & Schebb, N. H. (2013). Comparison of free serum oxylipin concentrations in hyper- vs. normolipidemic men. Prostaglandins Leukotrienes and Essential Fatty Acids, 89, 19–29.
Konkel, A., & Schunck, W. H. (2011). Role of cytochrome P450 enzymes in the bioactivation of polyunsaturated fatty acids. Biochimica et Biophysica Acta, 1814, 210–222.
Harris, T. R., & Hammock, B. D. (2013). Soluble epoxide hydrolase: gene structure, expression and deletion. Gene, 526, 61–74.
Imig, J. D., & Hammock, B. D. (2009). Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases. Nat Rev Drug Discov, 8, 794–805.
Ozawa, T., Hayakawa, M., Takamura, T., Sugiyama, S., Suzuki, K., Iwata, M., Taki, F., & Tomita, T. (1986). Biosynthesis of leukotoxin, 9,10-epoxy-12 octadecenoate, by leukocytes in lung lavages of rat after exposure to hyperoxia. Biochemical and Biophysical Research Communications, 134, 1071–1078.
Ishizaki, T., Shigemori, K., Nakai, T., Miyabo, S., Ozawa, T., Chang, S. W., & Voelkel, N. F. (1995). Leukotoxin, 9,10-Epoxy-12-Octadecenoate Causes Edematous Lung Injury Via Activation of Vascular Nitric-Oxide Synthase. American Journal of Physiology-Lung Cellular and Molecular Physiology, 269, L65–L70.
Sigfried, M. R. A., N.; Lefer, A. M.; Elisseou, E. M.; Zipkin, R.E (1990). Direct cardiovascular actions of two metabolites of linoleic acid. Life Sciences, 46, 427–433.
Sugiyama, S., Hayakawa, M., Nagai, S., Ajioka, M., & Ozawa, T. (1987). Leukotoxin, 9, 10-epoxy-12-octadecenoate, causes cardiac failure in dogs. Life Sciences, 40, 225–231.
Li, N., Liu, J. Y., Timofeyev, V., Qiu, H., Hwang, S. H., Tuteja, D., … Chiamvimonvat, N. (2009). Beneficial effects of soluble epoxide hydrolase inhibitors in myocardial infarction model: Insight gained using metabolomic approaches. Journal of Molecular and Cellular Cardiology, 47, 835–845.
Seubert, J. M., Sinal, C. J., Graves, J., DeGraff, L. M., Bradbury, J. A., Lee, C. R., … Zeldin, D. C. (2006). Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function. Circulation Research, 99, 442–450.
Hayakawa, M., Kosaka, K., Sugiyama, S., Yokoo, K., Aoyama, H., Izawa, Y., & Ozawa, T. (1990). Proposal of leukotoxin, 9,10-epoxy-12-octadecenoate, as a burn toxin. Biochemistry International, 21, 573–579.
Kosaka, K., Suzuki, K., Hayakawa, M., Sugiyama, S., & Ozawa, T. (1994). Leukotoxin, a linoleate epoxide: its implication in the late death of patients with extensive burns. Molecular and Cellular Biochemistry, 139, 141–148.
Edin, M. L., Wang, Z., Bradbury, J. A., Graves, J. P., Lih, F. B., DeGraff, L. M., Foley, J. F., Torphy, R., Ronnekleiv, O. K., Tomer, K. B., Lee, C. R., & Zeldin, D. C. (2011). Endothelial expression of human cytochrome P450 epoxygenase CYP2C8 increases susceptibility to ischemia-reperfusion injury in isolated mouse heart. The FASEB Journal, 25, 3436–3447.
Greene, J. F., Williamson, K. C., Newman, J. W., Morisseau, C., & Hammock, B. D. (2000). Metabolism of monoepoxides of methyl linoleate: bioactivation and detoxification. Archives of Biochemistry and Biophysics, 376, 420–432.
Sakai, T., Ishizaki, T., Ohnishi, T., Sasaki, F., Ameshima, S., Nakai, T., Miyabo, S., Matsukawa, S., Hayakawa, M., & Ozawa, T. (1995). Leukotoxin, 9,10-epoxy-12-octadecenoate inhibits mitochondrial respiration of isolated perfused rat lung. American Journal of Physiology, 269, L326–L331.
Thompson, D. A., & Hammock, B. D. (2007). Dihydroxyoctadecamonoenoate esters inhibit the neutrophil respiratory burst. J Biosci., 32, 279–291.
Dudda, A., Spiteller, G., & Kobelt, F. (1996). Lipid oxidation products in ischemic porcine heart tissue. Chemistry and Physics of Lipids, 82, 39–51.
Stimers, J. R., Dobretsov, M., Hastings, S. L., Jude, A. R., & Grant, D. F. (1999). Effects of linoleic acid metabolites on electrical activity in adult rat ventricular myocytes. Biochimica et Biophysica Acta, 1438, 359–368.
Harrell, M. D., & Stimers, J. R. (2002). Differential effects of linoleic Acid metabolites on cardiac sodium current. Journal of Pharmacology and Experimental Therapeutics, 303, 347–355.
Ha, J., Dobretsov, M., Kurten, R. C., Grant, D. F., & Stimers, J. R. (2002). Effect of linoleic acid metabolites on Na(+)/K(+) pump current in N20.1 oligodendrocytes: role of membrane fluidity. Toxicology and Applied Pharmacology, 182, 76–83.
Sisemore, M. F., Zheng, J., Yang, J. C., Thompson, D. A., Plopper, C. G., Cortopassi, G. A., & Hammock, B. D. (2001). Cellular characterization of leukotoxin diol-induced mitochondrial dysfunction. Archives of Biochemistry and Biophysics, 392, 32–37.
Moghaddam, M. F., Grant, D. F., Cheek, J. M., Greene, J. F., Williamson, K. C., & Hammock, B. D. (1997). Bioactivation of leukotoxins to their toxic diols by epoxide hydrolase. Nature Medicine, 3, 562–566.
Lee, J. P., Yang, S. H., Lee, H. Y., Kim, B., Cho, J. Y., Paik, J. H., Oh, Y. J., Kim, D. K., Lim, C. S., & Kim, Y. S. (2012). Soluble epoxide hydrolase activity determines the severity of ischemia-reperfusion injury in kidney. PLoS ONE, 7, e37075.
Chaudhary, K. R., Zordoky, B. N., Edin, M. L., Alsaleh, N., El-Kadi, A. O., Zeldin, D. C., & Seubert, J. M. (2013). Differential effects of soluble epoxide hydrolase inhibition and CYP2J2 overexpression on postischemic cardiac function in aged mice. Prostaglandins Other Lipid Mediat, 104–105, 8–17.
Mitchell, L. A., Moran, J. H., & Grant, D. F. (2002). Linoleic acid, cis-epoxyoctadecenoic acids, and dihydroxyoctadecadienoic acids are toxic to Sf-21 cells in the absence of albumin. Toxicology Letters, 126, 187–196.
Moran, J. H., Nowak, G., & Grant, D. F. (2001). Analysis of the toxic effects of linoleic acid, 12,13-cis-epoxyoctadecenoic acid, and 12,13-dihydroxyoctadecenoic acid in rabbit renal cortical mitochondria. Toxicology and Applied Pharmacology, 172, 150–161.
Motoki, A., Merkel, M. J., Packwood, W. H., Cao, Z., Liu, L., Iliff, J., Alkayed, N. J., & Van Winkle, D. M. (2008). Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo. American Journal of Physiology Heart and Circulatory Physiology, 295, H2128–H2134.
Viswanathan, S., Hammock, B. D., Newman, J. W., Meerarani, P., Toborek, M., & Hennig, B. (2003). Involvement of CYP 2C9 in mediating the proinflammatory effects of linoleic acid in vascular endothelial cells. Journal of the American College of Nutrition, 22, 502–510.
Di Lisa, F., Canton, M., Menabo, R., Kaludercic, N., & Bernardi, P. (2007). Mitochondria and cardioprotection. Heart Failure Reviews, 12, 249–260.
Spector, A. A., Fang, X., Snyder, G. D., & Weintraub, N. L. (2004). Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function. Progress in Lipid Research, 43, 55–90.
Spector, A. A., & Kim, H. Y. (2015). Cytochrome P450 epoxygenase pathway of polyunsaturated fatty acid metabolism. Biochimica et Biophysica Acta, 1851, 356–365.
Lu, T., VanRollins, M., & Lee, H. C. (2002). Stereospecific activation of cardiac ATP-sensitive K(+) channels by epoxyeicosatrienoic acids: a structural determinant study. Molecular Pharmacology, 62, 1076–1083.
Cabral, M., Martin-Venegas, R., & Moreno, J. J. (2014). Differential cell growth/apoptosis behavior of 13-hydroxyoctadecadienoic acid enantiomers in a colorectal cancer cell line. American Journal of Physiology. Gastrointestinal and Liver Physiology, 307, G664–G671.
Acknowledgements
In this work results of the dissertation “Effekte der Linolsäurederivate 12,13-Epoxyoctadecensäure(-methylester) und 12,13-Dihydroxyoctadecensäure(-methylester) auf das isolierte murine Herz” by Marwin Bannehr submitted in 2019 to Charité - Universitätsmedizin Berlin have been included. The authors thank Bastian Spallek, Michael Gotthardt and Ingo Morano for technical support and assistance during the experiments.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
All authors have nothing to disclose.
Additional information
Handling Editor: Y. James Kang.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Bannehr, M., Löhr, L., Gelep, J. et al. Linoleic Acid Metabolite DiHOME Decreases Post-ischemic Cardiac Recovery in Murine Hearts. Cardiovasc Toxicol 19, 365–371 (2019). https://doi.org/10.1007/s12012-019-09508-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12012-019-09508-x